Sinopharm Group Co. Ltd. | Mutual Funds
Mutual Funds that own Sinopharm Group Co. Ltd.
Oppenheimer Developing Markets Fund
172,897,200
14.5%
0
2.34%
02/28/2018
Matthews Pacific Tiger Fund
66,146,400
5.55%
0
3.62%
06/29/2018
Trimark Fund
17,899,600
1.5%
0
2.73%
03/31/2018
Vanguard Emerging Markets Stock Index Fund
16,062,777
1.35%
-112,000
0.1%
07/31/2018
Templeton Foreign Fund
15,295,130
1.28%
0
1.12%
03/31/2018
Fidelity Funds SICAV - Emerging Markets Fund
15,087,321
1.26%
-22,275
1.27%
05/31/2018
Vanguard Total International Stock Index Fund
14,548,297
1.22%
202,400
0.02%
07/31/2018
Hang Seng H-Shares Index ETF
12,754,569
1.07%
-1,751,743
1.49%
05/31/2018
Baron Emerging Markets Fund
12,328,950
1.03%
-38,622
1.17%
06/30/2018
Government Pension Fund - Global (The)
12,041,502
1.01%
-541,578
0.01%
12/31/2017
| Address |
Sinopharm Plaza
Shanghai Shanghai 200051
China
|
|
Employees
|
- |
| Website |
http://www.sinopharmholding.com |
| Updated |
07/08/2019 |
| Sinopharm Group Co., Ltd. is a distributor of pharmaceutical and healthcare products and a value added supply chain service provider in the People's Republic of China. It operates through the following business segments: Pharmaceutical Distribution, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment provides distribution, logistics and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers and other suppliers. |
